ACOR - How to Evaluate Acorda Therapeutics by Looking at the Charts

When influential investors make decisions to buy and sell securities, they normally want to keep it quiet.  However, if we pay close attention we can see what is going on, and make good decisions.. The Acorda Therapeutics (NASDAQ: ACOR) report below can help you understand how to do this. The trading plans for ACOR, are updated in real time for subscribers, but this report is static. If you want an update, or a different report on a different stock, please get one here Unlimited Real Time Reports .

Technical Summary

Long Term Trading Plans for ACOR

April 21, 2021, 6:30 am ET

The Technical Summary and Trading Plans for ACOR help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this ACOR Report.

ACOR - (Long) Support Plan

The technical summary data tells us to buy ACOR near 3.95 with an upside target of 5.49. This data also tells us to set a stop loss @ 3.94 to protect against excessive loss in case the stock begins to move against the trade. 3.95 is the first level of support below 4.15 , and by rule, any test of support is a buy signal. In this case, support 3.95 would be being tested, so a buy signal would exist.

ACOR - (Short) Resistance Plan

The technical summary data is suggesting a short of ACOR as it gets near 5.49 with a downside target of 3.95. We should have a stop loss in place at 5.51though. 5.49 is the first level of resistance above 4.15, and by rule, any test of resistance is a short signal. In this case, if resistance 5.49 is being tested, so a short signal would exist.